Vaporized cannabis versus placebo for acute migraine: A randomized, double‐blind, placebo‐controlled crossover trial
Acute migraine treatment with 6% THC + 11% CBD was superior to placebo at 2-h post-treatment with sustained benefits at 24 and 48 h.
Authors
- Thomas D. Marcotte (ORCID: https://orcid.org/0000-0002-3039-6400)
- Nathaniel M. Schuster (ORCID: https://orcid.org/0000-0002-4970-6296)
- Euyhyun Lee
- Michelle L. Sexton
- Mark S. Wallace (ORCID: https://orcid.org/0000-0001-5647-6233)
- Dawn C. Buse
- Lin Liu
Institutions
- Albert Einstein College of Medicine (US)
- UC San Diego Health System (US)
- University of California San Diego (US)
- Family Health Centers of San Diego (US)
- Human Longevity (United States) (US)
Publication Details
- Journal
- Headache The Journal of Head and Face Pain
- Published
- 2025-12-30
- DOI
- https://doi.org/10.1111/head.70025
- Citations
- 2
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 2.79